Norikazu Matsuo
Norikazu Matsuo publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Epidemiology, on topics such as Cancer Immunotherapy and Biomarkers, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Lung Cancer Treatments and Mutations.
- World rank
- #2,228,012 of 7,710,434 ranked researchers
- Rank in Japan
- #42,632 of 383,136
- Works
- 60
- Citations
- 1k
- Citations per work
- 17.0
What does Norikazu Matsuo research?
Norikazu Matsuo's work is mostly in Medicine (79%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences4778.6%
- Medicine4778.6%
- Everything else915.2%
- Life Sciences46.2%
- 1Pulmonary and Respiratory Medicine36% of their works
- 2Oncology28% of their works
- 3Epidemiology7% of their works
- 4Immunology6% of their works
- 5Physiology4% of their works
- 6Pathology and Forensic Medicine3% of their works
Research topics
- Cancer Immunotherapy and Biomarkers
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Inflammatory Myopathies and Dermatomyositis
- Sarcoidosis and Beryllium Toxicity Research
- Systemic Sclerosis and Related Diseases
Which keywords describe Norikazu Matsuo's research?
The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Interstitial Lung Disease, Fibrosis, Chemotherapy, Idiopathic Pulmonary Fibrosis, Immune Checkpoint Blockade and PD-1 and PD-L1.
- Pulmonary Involvement
- Inflammatory Myopathies
- Cardiac
- CT Screening
- Autoantibodies
- Genomic Profiles
- ALK Inhibitors
- PD-1 and PD-L1
- Idiopathic Pulmonary Fibrosis
- Fibrosis
- Targeted Therapy
- Clinical Trials
- Interstitial Lung Disease
- Chemotherapy
- Immune Checkpoint Blockade
- TGF-ß
- EGFR Mutations
- Small-Cell Lung Cancer
- Treatment
- Lung Cancer
- Dermatomyositis
- Sarcoidosis
- Systemic Sclerosis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Clinical Trials342 topics
- Targeted Therapy342 topics
- Interstitial Lung Disease262 topics
- Fibrosis252 topics
- Chemotherapy232 topics
- Idiopathic Pulmonary Fibrosis201 topic
- Immune Checkpoint Blockade201 topic
- PD-1 and PD-L1201 topic
- TGF-ß201 topic
- ALK Inhibitors181 topic
- EGFR Mutations181 topic
- Genomic Profiles161 topic
- Small-Cell Lung Cancer161 topic
- Autoantibodies112 topics
- Treatment112 topics
- CT Screening71 topic
- Lung Cancer71 topic
- Cardiac61 topic
- Dermatomyositis61 topic
- Inflammatory Myopathies61 topic
- Sarcoidosis61 topic
- Pulmonary Involvement51 topic
- Systemic Sclerosis51 topic
Where does Norikazu Matsuo work?
Norikazu Matsuo's main affiliation in the publication record is Kurume University, Japan.
How many publications and citations does Norikazu Matsuo have?
OpenAlex counts 60 works and 1,017 citations for Norikazu Matsuo, an h-index of 17, ranking #2,228,012 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Norikazu Matsuo. Posts are plain text and can be reported.